Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Bridgebio Pharma, Inc. Common Stock | BBIO

AI Analysis of Bridgebio Pharma, Inc. Common Stock

Bridgebio Pharma is up a bit on the day, funds flowing in kept the price up 1.56% since yesterday.

Currently BBIO isn't at a clear support/resistance line that seems tradable. Bridgebio Pharma hasn't established a very strong momentum in either direction over the last 3 months. We'll see if a stronger consensus among market participants emerges. BBIO might find some support at the 39.4 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2026-07-23

Companies with the highest correlation to Bridgebio Pharma

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
DNLI | Denali Therapeutics Inc. 0.750.166.26-4.7525.6922.1870.454138.8348.1791.33-1018.92-14795.020011.2371
UBER | Uber Technologies, Inc.0.72.84-0.35-5.94-8.18-6.77-21.4131-21.66-30.06-35.61-18376.84-272.68002.46538

Top 3 correlating companies

See full charts for all peers

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-